ARCHIVES

In Congress: Senate Committee Provides Increase To DOD Program

This article is from The Cancer Letter archive.

Vol. 23 No. 30 | August 1, 1997

Download PDF Visit The Full Archive

Related Articles

In Brief: Fredrickson Will Stay As NIH Director; NCI Group to Study Rhoads’ Clinical Center Idea

February 11, 1977

ODAC Advice Poses Challenge to FDA: Would Iressa Approval Erode Standards?

November 8, 2002

Cancer researchers support “responsible” human stem cell research.

July 22, 2005

ACS-Roosevelt Awards Announced

June 22, 1979

DCT Board Approves Drug Development Recompetition

November 30, 1990

FDA Approves Iressa For Third-Line Treatment Of Non-Small Cell Lung Cancer

May 9, 2003